Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NeuroTrauma Sciences LLC

Home Clinical Trial Sponsors and OrganizationsNeuroTrauma Sciences LLC

NeuroTrauma Sciences LLC

ACTIVE

佐治亚州, United Stateswww.neurotraumasciences.comPrivate11–50 employeesEstablished: 2016-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

66.7%

Phase 2

1

33.3%

Trial Status Distribution

Not yet recruiting

1

33.3%

Recruiting

1

33.3%

Terminated

1

33.3%

Clinical Trials

Trials sponsored by this organization (3)

A Phase 2a Study to Evaluate the Dose-response, Safety, Tolerability, Efficacy, and Population Pharmacokinetics of Intravenous NTS-521 Infusions in the Early Recovery Treatment From Acute Ischemic Stroke

Not yet recruiting

Oct 2026140 participants

Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults

May 202348 participants

A Study to Learn How Safe Different Doses of NTS-521 are, What the Amount of NTS-521 in the Body is Over a Period of Time, and What the Effects of NTS-521 on the Body and the Body on NTS-521 are in Adult and Elderly People Receiving Single and Multiple Doses of NTS-521 via an Infusion Directly into a Vein

104 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations